Cargando…

PLZF is a negative regulator of retinoic acid receptor transcriptional activity

BACKGROUND: Retinoic acid receptors (RARs) are ligand-regulated transcription factors controlling cellular proliferation and differentiation. Receptor-interacting proteins such as corepressors and coactivators play a crucial role in specifying the overall transcriptional activity of the receptor in...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Perrine J, Delmotte, Marie-Hélène, Formstecher, Pierre, Lefebvre, Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC212040/
https://www.ncbi.nlm.nih.gov/pubmed/14521715
http://dx.doi.org/10.1186/1478-1336-1-6
_version_ 1782120953239568384
author Martin, Perrine J
Delmotte, Marie-Hélène
Formstecher, Pierre
Lefebvre, Philippe
author_facet Martin, Perrine J
Delmotte, Marie-Hélène
Formstecher, Pierre
Lefebvre, Philippe
author_sort Martin, Perrine J
collection PubMed
description BACKGROUND: Retinoic acid receptors (RARs) are ligand-regulated transcription factors controlling cellular proliferation and differentiation. Receptor-interacting proteins such as corepressors and coactivators play a crucial role in specifying the overall transcriptional activity of the receptor in response to ligand treatment. Little is known however on how receptor activity is controlled by intermediary factors which interact with RARs in a ligand-independent manner. RESULTS: We have identified the promyelocytic leukemia zinc finger protein (PLZF), a transcriptional corepressor, to be a RAR-interacting protein using the yeast two-hybrid assay. We confirmed this interaction by GST-pull down assays and show that the PLZF N-terminal zinc finger domain is necessary and sufficient for PLZF to bind RAR. The RAR ligand binding domain displayed the highest affinity for PLZF, but corepressor and coactivator binding interfaces did not contribute to PLZF recruitment. The interaction was ligand-independent and correlated to a decreased transcriptional activity of the RXR-RAR heterodimer upon overexpression of PLZF. A similar transcriptional interference could be observed with the estrogen receptor alpha and the glucocorticoid receptor. We further show that PLZF is likely to act by preventing RXR-RAR heterodimerization, both in-vitro and in intact cells. CONCLUSION: Thus RAR and PLZF interact physically and functionally. Intriguingly, these two transcription factors play a determining role in hematopoiesis and regionalization of the hindbrain and may, upon chromosomal translocation, form fusion proteins. Our observations therefore define a novel mechanism by which RARs activity may be controlled.
format Text
id pubmed-212040
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-2120402003-10-11 PLZF is a negative regulator of retinoic acid receptor transcriptional activity Martin, Perrine J Delmotte, Marie-Hélène Formstecher, Pierre Lefebvre, Philippe Nucl Recept Research BACKGROUND: Retinoic acid receptors (RARs) are ligand-regulated transcription factors controlling cellular proliferation and differentiation. Receptor-interacting proteins such as corepressors and coactivators play a crucial role in specifying the overall transcriptional activity of the receptor in response to ligand treatment. Little is known however on how receptor activity is controlled by intermediary factors which interact with RARs in a ligand-independent manner. RESULTS: We have identified the promyelocytic leukemia zinc finger protein (PLZF), a transcriptional corepressor, to be a RAR-interacting protein using the yeast two-hybrid assay. We confirmed this interaction by GST-pull down assays and show that the PLZF N-terminal zinc finger domain is necessary and sufficient for PLZF to bind RAR. The RAR ligand binding domain displayed the highest affinity for PLZF, but corepressor and coactivator binding interfaces did not contribute to PLZF recruitment. The interaction was ligand-independent and correlated to a decreased transcriptional activity of the RXR-RAR heterodimer upon overexpression of PLZF. A similar transcriptional interference could be observed with the estrogen receptor alpha and the glucocorticoid receptor. We further show that PLZF is likely to act by preventing RXR-RAR heterodimerization, both in-vitro and in intact cells. CONCLUSION: Thus RAR and PLZF interact physically and functionally. Intriguingly, these two transcription factors play a determining role in hematopoiesis and regionalization of the hindbrain and may, upon chromosomal translocation, form fusion proteins. Our observations therefore define a novel mechanism by which RARs activity may be controlled. BioMed Central 2003-09-06 /pmc/articles/PMC212040/ /pubmed/14521715 http://dx.doi.org/10.1186/1478-1336-1-6 Text en Copyright © 2003 Martin et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Martin, Perrine J
Delmotte, Marie-Hélène
Formstecher, Pierre
Lefebvre, Philippe
PLZF is a negative regulator of retinoic acid receptor transcriptional activity
title PLZF is a negative regulator of retinoic acid receptor transcriptional activity
title_full PLZF is a negative regulator of retinoic acid receptor transcriptional activity
title_fullStr PLZF is a negative regulator of retinoic acid receptor transcriptional activity
title_full_unstemmed PLZF is a negative regulator of retinoic acid receptor transcriptional activity
title_short PLZF is a negative regulator of retinoic acid receptor transcriptional activity
title_sort plzf is a negative regulator of retinoic acid receptor transcriptional activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC212040/
https://www.ncbi.nlm.nih.gov/pubmed/14521715
http://dx.doi.org/10.1186/1478-1336-1-6
work_keys_str_mv AT martinperrinej plzfisanegativeregulatorofretinoicacidreceptortranscriptionalactivity
AT delmottemariehelene plzfisanegativeregulatorofretinoicacidreceptortranscriptionalactivity
AT formstecherpierre plzfisanegativeregulatorofretinoicacidreceptortranscriptionalactivity
AT lefebvrephilippe plzfisanegativeregulatorofretinoicacidreceptortranscriptionalactivity